
M&A & Strategic Deals: Dealmaking Shows New Signs of Life but FTC Scrutiny Casts a Dark Shadow
After a significant lull, M&As in the lab diagnostics space heated up in May, with several key deals announced.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LABORATORY INDUSTRY REPORT
NATIONAL LAB REPORTER
After a significant lull, M&As in the lab diagnostics space heated up in May, with several key deals announced.
On March 27, the agency released a new guidance document to help test developers make the transition to full approval.
A recently released report estimates that the US market will grow at a CAGR of 4.2 percent over the next seven years.
According to the FDA’s recently-released annual report, only 135 devices received the designation last year, versus 213 in 2021.
Roche and Abbott received the most approvals for new lab tests last year.